Illumina Investing Cash Flow decreased by 617.6% to -$366.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 481.0%, from -$63.00M to -$366.00M. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows an upward trend with a -45.0% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | -$2.45B | $0.00 | -$74.00M | -$165.00M | -$250.00M | -$102.00M | -$56.00M | -$37.00M | -$53.00M | -$85.00M | -$48.00M | -$41.00M | -$41.00M | -$48.00M | -$63.00M | -$49.00M | -$51.00M | -$366.00M |
| QoQ Change | — | <-999% | +100.0% | — | -123.0% | -51.5% | +59.2% | +45.1% | +33.9% | -43.2% | -60.4% | +43.5% | +14.6% | +0.0% | -17.1% | -31.3% | +22.2% | -4.1% | -617.6% |
| YoY Change | — | — | — | — | <-999% | +89.8% | — | +24.3% | +77.6% | +78.8% | +16.7% | +14.3% | -10.8% | +22.6% | +43.5% | -31.3% | -19.5% | -24.4% | -481.0% |